Oxurion Receives Transparency Notifications from Negma Group februari 24, 20230OpmerkingenEN NL Read More
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA februari 24, 20230OpmerkingenEN NL Read More
Oxurion Receives Transparency Notifications from Negma Group februari 17, 20230OpmerkingenEN NL Read More
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA februari 17, 20230OpmerkingenEN NL Read More
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA februari 10, 20230OpmerkingenEN NL Read More
Oxurion Receives Transparency Notifications from Negma Group februari 3, 20230OpmerkingenEN NL Read More
Oxurion Provides Further Details Concerning the Second Amendment to Negma Funding Program januari 27, 20230OpmerkingenEN Read More
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA januari 27, 20230OpmerkingenEN NL Read More
Biotech Showcase @JPM Week 2023 – San Francisco, CA januari 9, 20230OpmerkingenJanuary 9 - January 11, 2023 Read More
Jaarverslag 2022 (officiële ESEF-versie) december 30, 20220OpmerkingenJaarverslag 2022 (officiële ESEF-versie) Read More
Annual report 2022 (official ESEF version) december 30, 20220OpmerkingenAnnual report 2022 (official ESEF version)Read More
Oxurion Receives Transparency Notifications from Negma Group december 21, 20220OpmerkingenEN NL Read More
Oxurion Receives Transparency Notification from Negma Group december 21, 20220OpmerkingenEN NL Read More
Oxurion Receives Transparency Notifications from Negma Group december 19, 20220OpmerkingenEN NL Read More
